Brief: Irlab Gets Acceptance For Two Abstracts At 20Th International Conference On Alzheimer’s, Parkinson’s Diseases

IRLAB Therapeutics AB

07/11/2025 06:06

Nov 7 (Reuters) - IRLAB Therapeutics AB IRLABa.ST:

IRLAB RECEIVES ACCEPTANCE FOR TWO ABSTRACTS AT AD/PD™ 2026: THE 20TH INTERNATIONAL CONFERENCE ON ALZHEIMER’S AND PARKINSON’S DISEASES

Source text: ID:nMFNbn3MJ1

Further company coverage: [IRLABa.ST]

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))